CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...

ABBOTT PARK, Ill., and WATERTOWN, Mass., Feb. 18, 2009 - Abbott and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration with a first-in-human study ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases ...

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral ...

HIV-1 protease inhibitors (PIs) have long been central to antiretroviral therapy, directly targeting the enzyme responsible for processing viral polyproteins into functional units. Their efficacy, ...

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has been spreading rampantly over the whole world, infecting millions of people (over 8.45 million at last count), with over ...

Genoscience’s molecular modeling capabilities will be coupled with RFS Pharma’s drug development expertise. RFS Pharma and Genoscience Pharma formed a drug discovery joint venture to develop protease ...

In a recent study posted to the bioRxiv* pre-print server, a team of researchers discovered S-217622, a non-covalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease ...

Social media users have questioned why a treatment approved to treat COVID-19 contains an HIV protease inhibitor. It comes after the United States authorised Pfizer's antiviral Paxlovid as the first ...

We report a bacterial system for the evolution of cyclic peptides that makes use of an expanded set of amino acid building blocks. Orthogonal aminoacyl-tRNA synthetase/tRNACUA pairs, together with a ...